Zhenru X. Wu
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 97 publications
Whole-Exome Sequencing Identifies Frequent AHNAK2 Mutations With Prognostic Significance in Undifferentiated Primary Liver Carcinoma.
Journal: The American journal of surgical pathology
Published: April 24, 2026
Nakagami Statistics-Based Parametric Thermoacoustic Imaging for Assessment of Liver Microwave Ablation.
Journal: Bioengineering (Basel, Switzerland)
Published: March 31, 2026
LPCAT1 and MRPL9 Promote Hepatocellular Carcinoma Progression via AKT Phosphorylation and Define a Mitochondrial Prognostic Model.
Journal: Cancers
Published: February 06, 2026
Salvage resection for FGFR2 fusion-positive intrahepatic cholangiocarcinoma after pemigatinib therapy: a case report and literature review.
Journal: Frontiers in oncology
Published: January 29, 2026
A selective BRG1 inhibitor targeting bromodomain sensitizes hepatocellular carcinoma to chemoradiotherapy by disrupting the DNA damage response.
Journal: Chinese medical journal
Published: January 12, 2026
A Dichloropropionamide-Substituted Diaminopyrimidine EGFR-TKI Overcomes Osimertinib Resistance in NSCLC via Dual Anchoring at Ser797 and Met793.
Journal: Journal of medicinal chemistry
Published: December 22, 2025
In vivo generation of fibrolytic macrophages via LNP-CSF1 mRNA attenuates liver fibrosis.
Journal: Journal of nanobiotechnology
Published: December 12, 2025
MRI-based prediction of very early recurrence within 1 year after resection of HCC: An international cohort study.
Journal: Journal of hepatology
Published: December 09, 2025
Targeting circGDI2 disrupt HNRNPC-mediated mPORCN stabilization and enhance LGK-974 anti-tumor therapy in hepatocellular carcinoma.
Journal: Molecular cancer
Published: September 26, 2025
Tumor-derived ITIH2 activates PI3K\AKT pathway via THBS1 ubiquitination and promotes tumor angiogenesis in hepatocellular carcinoma.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: August 20, 2025
L-lactate-driven PSMD14 lactylation and stabilization promote lactate production and ferroptosis resistance via ENO1 in intrahepatic cholangiocarcinoma.
Journal: Cancer letters
Published: August 07, 2025
KAT2A-driven succinylation of SRSF11 enforces spliceosome-mediated RAD52 splicing to promote homologous recombination and radioresistance in hepatocellular carcinoma.
Journal: Signal transduction and targeted therapy
Published: June 03, 2025
Last Updated: 09/26/2026